Artificial Intelligence: Microsoft Eyeing Acquisition of Nuance Communications (Bloomberg)
Nuance is an AI and speech technology company.
Microsoft (NASDAQ: MSFT) may buy Nuance Communication (NASDAQ: NUAN) at a valuation of $56 per share, according to Bloomberg, which cited unnamed people who were familiar with the matter. The price represents a premium of 23% over the Friday closing of Nuance of $45.58.
The talks, though in an advanced stage, could still break down without a deal being reached. At the said price, NUAN would be valued at $16 billion.
However, negotiations may also be successful and an announcement could be made as early as this week.
NUAN is a leader in conversational AI applied in healthcare, customer engagement, security, and speech recognition productivity.
In September, Nuance and Microsoft announced the integration of an artificial intelligence-based clinical solution into Microsoft Teams to capture all details of clinical telemedicine via accurate documentation.
Physicians and doctors can activate the Nuance Dragon Ambient eXperience (DAX) directly from within their Microsoft Teams. The ambient clinical intelligence (ACI) solution securely captures the details of the virtual teleconsultation. It also creates clinical documentation that writes itself.
“Our strategic partnership with Microsoft, which led to this rapid integration of DAX with Microsoft Teams for telehealth, illustrates the ongoing importance of combining our technologies, domain expertise, and market reach,” said Diana Nole, executive vice president, and general manager of healthcare, Nuance, at the time.
There has been a dramatic rise in telehealth patient volumes since the onset of the pandemic.
Image Source: Twitter
Latest Alternative Investment News
Though initial reports said that Colonial Pipeline would not pay a ransom to the hackers that brought the nation’s largest fuel pipeline to a halt, Bloomberg reported Thursday that the…
Artificial Intelligence: A Molecule For Alzheimer’s Created By Exscientia’s AI Enters Clinical Trials
Oxford, UK-based Exscientia uses AI to design and create drug candidate molecules satisfying complex therapeutic requirements with revolutionary efficiency. Joint research by Exscientia with Sumitomo Dainippon Pharma Co., Ltd. (TYO:…
Vinted, a European startup that runs a marketplace for used clothing and home goods, announced its raise of $303 million at a valuation of $4.5 billion, post-money. That valuation is…
On Wednesday, Germany’s Federal Financial Supervisory Authority (BaFin) ordered challenger bank N26 to implement appropriate internal controls and safeguards and comply with general due diligence requirements to prevent money laundering…